pegfilgrastim

It is used in adults to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy. The medicine stimulates the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection in pre-filled syringe

ATC: L03AA13

Manufacturer: MUNDIPHARMA CORPORATION (IRELAND) LIMITED

Dyrupeg is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy in adults aged 18 years and older. The drug stimulates the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection in pre-filled syringe

ATC: L03AA13

Manufacturer: CURATEQ BIOLOGICS S.R.O

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia that may be caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Grasustek is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia that may be caused by cytotoxic chemotherapy. The drug stimulates the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: JUTA PHARMA GMBH

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: AMGEN EUROPE B.V.

It is used in adults undergoing chemotherapy to reduce the duration of neutropenia (a low white blood cell count) and to prevent febrile neutropenia.

Form: solution for injection

ATC: L03AA13

Manufacturer: PFIZER EUROPE MA EEIG

It is used to reduce the duration and occurrence of neutropenia (low white blood cell count) and febrile neutropenia caused by cytotoxic chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used in adults to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by cytotoxic chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: MUNDIPHARMA CORPORATION (IRELAND) LIMITED

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia that may be caused by chemotherapy. The drug stimulates the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection in pre-filled syringe

ATC: L03AA13

Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.

Form: solution for injection

ATC: L03AA13

Manufacturer: SANDOZ GMBH